2020 年中国广州 COVID-19 大流行下鼻病毒的流行病学。
Epidemiology of rhinovirus under the COVID-19 pandemic in Guangzhou, China, 2020.
机构信息
Director, Guangzhou Baiyun District Center for Disease Control and Prevention, Guangzhou, Guangdong, P. R. China.
Institute of Human Virology | Zhongshan School of Medicine | Key Laboratory of Tropical Disease Control of Ministry of Education, Sun Yat-sen University, Guangzhou, P. R. China.
出版信息
Immun Inflamm Dis. 2022 Jun;10(6):e632. doi: 10.1002/iid3.632.
BACKGROUND
To analyze the epidemic characteristics of the human rhinovirus (HRV) outbreaks in Guangzhou, China, in 2020.
METHODS
Descriptive epidemiological methods were used to analyze the HRV-related outbreaks in Guangzhou, 2020.
RESULTS
Seventeen outbreaks were reported in 2020 during the coronavirus disease 2019 (COVID-19) pandemic in Guangzhou, a total of 465 patients (290 males and 175 females) were enrolled, with a median age of 10. A total of 223 (47.96%) had been tested for HRV, 89 (39.91%) of which were positive; 344/465 (73.98%) had a fever, 138/465 (29.68%) had a runny nose, 139/465 (29.89%) had a sore throat, 86/465 (18.49%) had a cough, 41/465 (8.82%) had a headache, and 37/465 (7.96%) had a sneeze. Patients at age of 13-15 had the highest rate of sore throat and runny nose, patients aged 11-12 had the highest rate of sneezing, and patients at age of 12-14 had the highest rate of positive rate. Patients tested positive had a higher rate of fever (χ = 11.271, p = .001), cough (χ = 6.987, p = .008), runny nose (χ = 7.980, p = .005), and sneeze (χ = 4.676, p = .031).
CONCLUSION
The HRV was restored during the fighting of the COVID-19 pandemic. The conventional COVID-19 control measures were not effective enough in preventing rhinovirus. More appropriate control measures should be used to control HRV.
背景
分析 2020 年中国广州人类鼻病毒（HRV）暴发的流行特征。
方法
采用描述性流行病学方法分析 2020 年广州 HRV 相关暴发情况。
结果
2020 年在广州新冠肺炎（COVID-19）大流行期间报告了 17 起暴发，共纳入 465 例患者（男 290 例，女 175 例），中位年龄为 10 岁。共有 223 例（47.96%）进行了 HRV 检测，其中 89 例（39.91%）阳性；465 例患者中 344 例（73.98%）发热，138 例（29.68%）流涕，139 例（29.89%）咽痛，86 例（18.49%）咳嗽，41 例（8.82%）头痛，37 例（7.96%）打喷嚏。13-15 岁年龄组咽痛和流涕发生率最高，11-12 岁年龄组打喷嚏发生率最高，12-14 岁年龄组阳性率最高。检测阳性患者发热（χ ²=11.271，p=0.001）、咳嗽（χ ²=6.987，p=0.008）、流涕（χ ²=7.980，p=0.005）和打喷嚏（χ ²=4.676，p=0.031）的比例更高。
结论
在抗击新冠肺炎疫情期间，HRV 得以恢复。常规的新冠肺炎控制措施对预防鼻病毒效果不佳，应采用更恰当的控制措施来控制 HRV。
Zotero 插件